We are live on ! Find out more
AWE

Avidian Wealth Enterprises Portfolio holdings

AUM $3.62B
1-Year Est. Return 24.81%
This Fund
S&P 500
This Quarter Est. Return
-1.14%
1 Year Est. Return
+24.81%
3 Year Est. Return
+63.73%
5 Year Est. Return
+69.22%
10 Year Est. Return
+195.62%
AUM
$1.31B
AUM Growth
+$9.23M
Cap. Flow
+$112M
Cap. Flow %
8.56%
Top 10 Hldgs %
44.67%
Holding
434
New
41
Increased
222
Reduced
83
Closed
47
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
126
Oracle
ORCL
$374B
$1.07M 0.08%
12,295
+2,524
+26% +$223K
PHYS icon
127
Sprott Physical Gold
PHYS
$14.6B
$1.07M 0.08%
77,550
TGT icon
128
Target
TGT
$65.6B
$1.06M 0.08%
4,656
+187
+4% +$46.8K
MRK icon
129
Merck
MRK
$322B
$1.06M 0.08%
14,167
+2,282
+19% +$174K
ABTX
130
DELISTED
Allegiance Bancshares
ABTX
$1.03M 0.08%
27,138
-1,835
-6% -$67.3K
SLB icon
131
SLB Ltd
SLB
$73.6B
$1.01M 0.08%
34,096
+2,202
+7% +$63.1K
ADM icon
132
Archer Daniels Midland
ADM
$38.2B
$1.01M 0.08%
16,767
+541
+3% +$32.4K
MGK icon
133
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
$991K 0.08%
21,100
+505
+2% +$24.4K
NKE icon
134
Nike
NKE
$61.9B
$981K 0.07%
6,754
+925
+16% +$151K
KMI icon
135
Kinder Morgan
KMI
$71.7B
$952K 0.07%
56,892
+2,613
+5% +$44.4K
TMO icon
136
Thermo Fisher Scientific
TMO
$213B
$948K 0.07%
1,660
-192
-10% -$105K
IWD icon
137
iShares Russell 1000 Value ETF
IWD
$82.2B
$921K 0.07%
5,887
+12
+0.2% +$1.92K
BMY icon
138
Bristol-Myers Squibb
BMY
$133B
$919K 0.07%
15,537
+5,445
+54% +$359K
LLY icon
139
Eli Lilly
LLY
$1.02T
$911K 0.07%
3,941
+395
+11% +$97.5K
PFXF icon
140
VanEck Preferred Securities ex Financials ETF
PFXF
$2.41B
$905K 0.07%
42,671
+15,196
+55% +$326K
MMM icon
141
3M
MMM
$90.9B
$904K 0.07%
6,165
+1,314
+27% +$213K
LUV icon
142
Southwest Airlines
LUV
$22B
$869K 0.07%
16,896
+7,951
+89% +$402K
GD icon
143
General Dynamics
GD
$104B
$860K 0.07%
4,389
+662
+18% +$130K
NVDA icon
144
NVIDIA
NVDA
$4.86T
$849K 0.06%
40,980
+10,820
+36% +$225K
NOBL icon
145
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
$840K 0.06%
18,972
-588
-3% -$27.1K
DIA icon
146
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$838K 0.06%
2,478
+3
+0.1% +$1.05K
LOW icon
147
Lowe's Companies
LOW
$117B
$838K 0.06%
4,130
+45
+1% +$8.97K
RDS.A
148
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$838K 0.06%
18,797
-616
-3% -$24.9K
CHRW icon
149
C.H. Robinson
CHRW
$17.4B
$837K 0.06%
9,624
+3,176
+49% +$287K
SRNE
150
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$832K 0.06%
109,000
-40
-0% -$339

Similar funds

Avidian Wealth Enterprises's Q3 2021 Portfolio in Review

As of Q3 2021, Avidian Wealth Enterprises held 434 positions worth $1.31B, up 0.71% from $1.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Avidian Wealth Enterprises deployed $112M of net new capital in Q3 2021, opening 41 new positions and adding to 222 existing holdings. Its largest new stake was iShares Currency Hedged MSCI Eurozone ETF: 239,109 shares worth $8.62M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 6.4% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Vanguard Russell 1000 Value ETF, an estimated $11.6M trimmed.

  • Avidian Wealth Enterprises's largest Q3 2021 buy was iShares Currency Hedged MSCI Eurozone ETF: 239,109 shares worth $8.62M.
  • Avidian Wealth Enterprises added most to iShares MSCI USA Quality Factor ETF in Q3 2021, an estimated $29.9M increase.
  • Avidian Wealth Enterprises's biggest Q3 2021 reduction was Vanguard Russell 1000 Value ETF, cutting an estimated $11.6M.
  • Avidian Wealth Enterprises fully exited State Street SPDR S&P 500 ETF Trust in Q3 2021, selling an estimated $14.8M.
  • Avidian Wealth Enterprises's ten largest holdings make up 45% of its $1.31B portfolio in Q3 2021.
  • Avidian Wealth Enterprises opened 41 new positions and closed 47 in Q3 2021.
  • Avidian Wealth Enterprises's portfolio value rose 0.71% quarter-over-quarter to $1.31B.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2021, filed 10 Nov 2021.